NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Dr Wael El Banna: How A Retroplacental Hematoma Looks Like In A Surgery Room
Dr Wael El Banna/LinkedIn
Oct 5, 2025, 08:30

Dr Wael El Banna: How A Retroplacental Hematoma Looks Like In A Surgery Room

 

Dr Wael El Banna, OBGYN Consultant at FertiClinic Fertilization Group, Owner of ElBanna Group, posted on LinkedIn:

”How a retroplacental hematoma looks like in a surgery room. (watch that video )

The key management steps are :

Immediate Resuscitation and Multidisciplinary Care

  • Initial focus is on maternal resuscitation following the ABC approach: airway, breathing, and circulation.
  • Management should be according to locally-created massive obstetric hemorrhage protocols, led by a senior obstetrician, anesthetist, haematologist, and the midwifery team, with laboratory and portering staff alerted.
  • Bloods should be immediately sent for blood grouping, crossmatch, full blood count, and coagulation screen, with 4 units of crossmatched blood prepared.
  • Senior and experienced staff should be involved as early as possible in both obstetric and anaesthetic roles.

Management of Coagulopathy

  • Disseminated intravascular coagulation (DIC) can develop rapidly in massive abruption; urgent clotting studies and platelet count are necessary.
  • Up to 4 units of fresh frozen plasma (FFP) and 10 units of cryoprecipitate can be administered empirically if relentless bleeding persists while awaiting test results.
  • Haematology input is vital for guiding further transfusions and clotting factor support.

Delivery

  • If maternal or fetal compromise is evident, immediate delivery is required.
  • Mode of delivery depends on fetal and maternal status:
  • If fetal death has occurred and maternal condition is stable, vaginal delivery is generally recommended.
  • If fetus is alive but compromised, expedite delivery by caesarean section, unless vaginal delivery is imminent.

Additional Considerations

  • Continuous maternal and fetal monitoring is essential during and after the acute event.
  • All RhD-negative women should receive anti-D immunoglobulin if more than 20 weeks gestation.
  • Ongoing monitoring for PPH, renal dysfunction, and further coagulopathy is needed post-delivery.
  • If the patient develops hypovolemia or shock, ICU-level support and ongoing multidisciplinary care are mandatory.”

 

 

Stay updated with Hemostasis Today.

Coagulopathy Dr Wael El Banna ElBanna Group FertiClinic Fertilization Group Gynecology Health Hematology Hemostasis Hemostasis Today Medicine Obstetrics Retroplacental Hematoma thrombosis
NewsFeed